Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR‐215757), a new quinoline‐3‐carboxamide derivative: Studies in lupus‐prone mice and a multicenter, randomized, double‐blind, placebo‐controlled, repeat‐dose, dose‐ranging study in patients with systemic lupus erythematosusAnders Bengtsson, Tomas Leanderson, Helén Tuvesson et al.|Arthritis & Rheumatism|2011Cited by 124